This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies
March 11-14, 2024 | Part of BPI West
Town and Country ResortSan Diego, CA

Yizhou Zhou, PhD
Head of Cell Line Technology, Gene Therapy Development at Biogen


Yizhou Zhou is a Scientist in the Cell Culture Development Team of Biogen. She is responsible for vector construction, molecular assay development, and clinical cell line development. She obtained Ph.D. in Molecular Biology at the University of Michigan and worked at Genentech before joining Biogen.

Agenda Sessions

  • Quality In, Quality Out: The Impact of Critical Starting Materials on rAAV Production using Transient Transfection